Previous 10 | Next 10 |
Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the upcoming UBS Genomics 2.0 and MedTech Innovations Summit. Guardant Health’s management is scheduled to participate in a fireside chat on Tuesday,...
Image source: The Motley Fool. Guardant Health, inc (NASDAQ: GH) Q2 2021 Earnings Call Aug 5, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Guardant Health, inc (GH) Q2 2021 Earnings Call Transcript
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Illumina’s (NASDAQ: ILMN ) strong growth and tremendous potential make ILMN stock worth buying. Source: Shutterstock It’s true that the company’s shares are not at all cheap. Still, the dema...
Guardant Health, Inc. (GH) Q2 2021 Earnings Conference Call August 5, 2021 4:30 PM ET Company Participants Carrie Mendivil – Investor Relations Helmy Eltoukhy – Chief Executive Officer AmirAli Talasaz – President Mike Bell – Chief Financial Officer Conference Call ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Mega cap growth stocks that have traded together and driv...
Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing. Baron Asset Fund increased 10.03% (Institutional Shares), while the Russell Midcap Growth Index increased 11.07%, and the S...
Selected Recipients of the New “Back to Screening Award for Research Advocacy Excellence” will be Honored at Fight Colorectal Cancer’s “Path to a Cure” Event in December 2021 Fight Colorectal Cancer (Fight CRC), the nation's leading colorec...
AI Startup Lunit Secures Investment from Guardant Health in a Strategic Funding Round PR Newswire SEOUL , Souh Korea, July 19, 2021 /PRNewswire/ -- Lunit, a leading AI startup in AI-powered cancer solutions, today announced a strategic investment of $26 million...
4X-image/iStock via Getty Images Guardant Health ([[GH]] -0.1%) has made a $26M investment in Lunit, a South Korea-based artificial intelligence-powered cancer solutions company. The investment also includes a collaboration between the two companies. Guardant provides diagnostic tests to help...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. Providing more formalized structure around the Strategy...
News, Short Squeeze, Breakout and More Instantly...
2024-05-11 09:16:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Revenue growth of 31% driven by strong clinical and biopharma volume and Guardant360 ASP tailwinds Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today reported financial results for the quarter ended March 31, 2024. First Quarter 2024 Financial Highligh...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...